| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Armed Forces Research Institute of Medical Science, Bangkok, Thailand
To establish the role of maternal dengue-specific antibodies in the development of dengue hemorrhagic fever and dengue shock syndrome caused by dengue 2 virus in infants, we examined sera from mothers of infants and toddlers with dengue hemorrhagic fever or dengue shock syndrome and mothers of infants with pyrexia of unknown origin. The mean titers of hemagglutination inhibition, neutralization, and infection-enhancing activities against dengue 2 virus were not statistically different among the three groups. However, among infants who developed dengue hemorrhagic fever/dengue shock syndrome there was a strong correlation between the mothers' dengue 2 neutralizing titers and infant age at the time of onset of severe illness, where no such correlation was found among the other two groups. Furthermore, the actual age at which dengue hemorrhagic fever/dengue shock syndrome occurred in each infant correlated with the age at which maximum enhancing activity for dengue 2 infection in mononuclear phagocytes was predicted. This critical time for the occurrence of dengue hemorrhagic fever/dengue shock syndrome was observed to be approximately 2 months after the time calculated for maternal dengue 2 neutralizing antibodies to degrade below a protective level. In addition, sera of mothers of infants with dengue hemorrhagic fever/dengue shock syndrome enhanced dengue 2 virus infection to a slightly greater degree than did sera from mothers of infants with pyrexia of unknown origin and toddlers with dengue hemorrhagic fever/dengue shock syndrome. These data are consistent with the hypothesis that maternal dengue antibodies play a dual role by first protecting and later increasing the risk of development of dengue hemorrhagic fever/dengue shock syndrome in infants who become infected by dengue 2 virus.
Accepted for publication August 24, 1987.
This article has been cited by other articles:
|
|
 |
|
  I. L. De Rivera, L. Parham, W. Murillo, W. Moncada, and S. Vazquez Humoral Immune Response of Dengue Hemorrhagic Fever Cases in Children from Tegucigalpa, Honduras Am J Trop Med Hyg, August 1, 2008; 79(2): 262 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Raviprakash, D. Wang, D. Ewing, D. H. Holman, K. Block, J. Woraratanadharm, L. Chen, C. Hayes, J. Y. Dong, and K. Porter A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue Virus J. Virol., July 15, 2008; 82(14): 6927 - 6934. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Boonnak, B. M. Slike, T. H. Burgess, R. M. Mason, S.-J. Wu, P. Sun, K. Porter, I. F. Rudiman, D. Yuwono, P. Puthavathana, et al. Role of Dendritic Cells in Antibody-Dependent Enhancement of Dengue Virus Infection J. Virol., April 15, 2008; 82(8): 3939 - 3951. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Nagao and K. Koelle Decreases in dengue transmission may act to increase the incidence of dengue hemorrhagic fever PNAS, February 12, 2008; 105(6): 2238 - 2243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Blackley, Z. Kou, H. Chen, M. Quinn, R. C. Rose, J. J. Schlesinger, M. Coppage, and X. Jin Primary Human Splenic Macrophages, but Not T or B Cells, Are the Principal Target Cells for Dengue Virus Infection In Vitro J. Virol., December 15, 2007; 81(24): 13325 - 13334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. V. Gibbons, S. Kalanarooj, R. G. Jarman, A. Nisalak, D. W. Vaughn, T. P. Endy, M. P. Mammen Jr, and A. Srikiatkhachorn Analysis of Repeat Hospital Admissions for Dengue to Estimate the Frequency of Third or Fourth Dengue Infections Resulting in Admissions and Dengue Hemorrhagic Fever, and Serotype Sequences Am J Trop Med Hyg, November 1, 2007; 77(5): 910 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Kraus, W. Messer, L. B. Haymore, and A. M. de Silva Comparison of Plaque- and Flow Cytometry-Based Methods for Measuring Dengue Virus Neutralization J. Clin. Microbiol., November 1, 2007; 45(11): 3777 - 3780. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. White, M. M. Parsons, A. C. Whitmore, B. M. Williams, A. de Silva, and R. E. Johnston An Immunogenic and Protective Alphavirus Replicon Particle-Based Dengue Vaccine Overcomes Maternal Antibody Interference in Weanling Mice J. Virol., October 1, 2007; 81(19): 10329 - 10339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Goncalvez, R. E. Engle, M. St. Claire, R. H. Purcell, and C.-J. Lai Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention PNAS, May 29, 2007; 104(22): 9422 - 9427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Chareonsirisuthigul, S. Kalayanarooj, and S. Ubol Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells J. Gen. Virol., February 1, 2007; 88(2): 365 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sun, C. M. Celluzzi, M. Marovich, H. Subramanian, M. Eller, S. Widjaja, D. Palmer, K. Porter, W. Sun, and T. Burgess CD40 Ligand Enhances Dengue Viral Infection of Dendritic Cells: A Possible Mechanism for T Cell-Mediated Immunopathology J. Immunol., November 1, 2006; 177(9): 6497 - 6503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Adams, E. C. Holmes, C. Zhang, M. P. Mammen Jr, S. Nimmannitya, S. Kalayanarooj, and M. Boots Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok PNAS, September 19, 2006; 103(38): 14234 - 14239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Domingo, G. Palacios, O. Jabado, N. Reyes, M. Niedrig, J. Gascon, M. Cabrerizo, W. I. Lipkin, and A. Tenorio Use of a Short Fragment of the C-Terminal E Gene for Detection and Characterization of Two New Lineages of Dengue Virus 1 in India J. Clin. Microbiol., April 1, 2006; 44(4): 1519 - 1529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. T. HUNG, N. T. LAN, H.-Y. LEI, Y.-S. LIN, L. B. LIEN, K.-J. HUANG, C.-F. LIN, D. Q. HA, V. T. Q. HUONG, L. T. MY, et al. VOLUME REPLACEMENT IN INFANTS WITH DENGUE HEMORRHAGIC FEVER/DENGUE SHOCK SYNDROME Am J Trop Med Hyg, April 1, 2006; 74(4): 684 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Mongkolsapaya, T. Duangchinda, W. Dejnirattisai, S. Vasanawathana, P. Avirutnan, A. Jairungsri, N. Khemnu, N. Tangthawornchaikul, P. Chotiyarnwong, K. Sae-Jang, et al. T Cell Responses in Dengue Hemorrhagic Fever: Are Cross-Reactive T Cells Suboptimal? J. Immunol., March 15, 2006; 176(6): 3821 - 3829. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-J. Huang, Y.-C. Yang, Y.-S. Lin, J.-H. Huang, H.-S. Liu, T.-M. Yeh, S.-H. Chen, C.-C. Liu, and H.-Y. Lei The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection. J. Immunol., March 1, 2006; 176(5): 2825 - 2832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. T. Cummings, I. B. Schwartz, L. Billings, L. B. Shaw, and D. S. Burke Dynamic effects of antibody-dependent enhancement on the fitness of viruses PNAS, October 18, 2005; 102(42): 15259 - 15264. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
